Overview

Effect of Rosuvastatin on the Clinical Features of Preeclampsia

Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The primary outcome will be the effect of rosuvastatin on the resolution of biochemical features associated with severe PE (↑CRP and IL6). .
Phase:
Phase 2
Details
Lead Sponsor:
Assiut University
Treatments:
Rosuvastatin Calcium